About 270 lawsuits have been filed just against Johnson & Johnson, with the rest naming C.R. Bard, Boston Scientific and American Medical Systems, which is being acquired by Endo Pharmaceuticals Holdings. So far, none of the cases have gone to trial.
In July, the FDA warned of a fivefold increase in women suffering pain and injuries after the mesh was inserted. Last week, an advisory panel agreed with FDA staff that the agency should reclassify mesh from moderate risk to high risk and require more studies to determine if it is safe and effective.
Related Articles on Vaginal Mesh:
FDA May Revoke Approvals of Transvaginal Mesh Products
Patient Safety Tool: Home Fall Prevention Checklist From CDC
FDA: Serious Complications Associated With Surgical Mesh for Transvaginal Repair of POP are Not Rare
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
